Long-term video EEG monitoring has range of benefits in epilepsy
For monitoring epilepsy, long-term monitoring can be effective without requiring the time and cost of a hospital stay.
Long-term video electroencephalogram monitoring (LVEM) is beneficial not only from a medical perspective but also is helpful for children with epilepsy and their families, even when patients are ineligible for epilepsy surgery, according to study findings. The retrospective study, conducted in Germany, included 163 patients who underwent LVEM sessions with a mean duration of 5.4 days. LVEM confirmed a diagnosis of epilepsy in 147 patients (90.2%) and excluded the diagnosis in 16 (9.2%). Overall, LVEM results altered the diagnosis of 37.4% of patients, 20.8% of presurgical patients, and 52.3% of those not slated for surgery. In 64% of patients deemed ineligible for surgery, the clarification of epilepsy syndromes through LVEM resulted in medication adjustments. Three months after undergoing LVEM or surgery, 81 patients (45.4%) reported having either no or fewer seizures. In response to a questionnaire, three-quarters of families indicated that they considered LVEM helpful, with 45.8% reporting that the patient’s illness had improved since undergoing the monitoring.
Thoughts from Dr. Farber
The pandemic has forced us to reconsider the value of some hospital stays. Here is another area where home appears to be better: lower cost, less stress for families, and a longer period of monitoring are 3 obvious benefits, without apparently sacrificing quality.
Reference
1. Mann C, Willems LM, Leyer AC, et al. Benefits, safety and outcomes of long-term video EEG monitoring in pediatric patients. Eur J Paediatr Neurol. March 10, 2021. Epub ahead of print. doi:10.1016/j.ejpn.2021.03.006
Seizures could be the cause of many sudden unexplained deaths in toddlers
January 9th 2024The study authors noted that without video evidence, seizures would not have been implicated in death investigations and that seizure-related deaths are underrecognized in patients with epilepsy and in those without.
FDA warns of serious potential reaction to levetiracetam and clobazam
November 30th 2023The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
